- Home
- CNMD vs RXRX Comparison
CNMD vs RXRX Comparison
Compare CNMD & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNMD
- RXRX
- Stock Information
- Founded
- CNMD 1970
- RXRX 2013
- Country
- CNMD United States
- RXRX United States
- Employees
- CNMD N/A
- RXRX N/A
- Industry
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- CNMD Health Care
- RXRX Health Care
- Exchange
- CNMD Nasdaq
- RXRX Nasdaq
- Market Cap
- CNMD 1.7B
- RXRX 2.0B
- IPO Year
- CNMD 1987
- RXRX 2021
- Fundamental
- Price
- CNMD $52.37
- RXRX $5.11
- Analyst Decision
- CNMD Hold
- RXRX Buy
- Analyst Count
- CNMD 5
- RXRX 5
- Target Price
- CNMD $62.20
- RXRX $7.00
- AVG Volume (30 Days)
- CNMD 385.8K
- RXRX 32.0M
- Earning Date
- CNMD 07-30-2025
- RXRX 08-07-2025
- Dividend Yield
- CNMD 1.53%
- RXRX N/A
- EPS Growth
- CNMD 46.38
- RXRX N/A
- EPS
- CNMD 3.81
- RXRX N/A
- Revenue
- CNMD $1,315,998,000.00
- RXRX $59,790,000.00
- Revenue This Year
- CNMD $6.27
- RXRX $23.51
- Revenue Next Year
- CNMD $5.62
- RXRX $53.87
- P/E Ratio
- CNMD $13.69
- RXRX N/A
- Revenue Growth
- CNMD 4.32
- RXRX 29.32
- 52 Week Low
- CNMD $46.00
- RXRX $3.79
- 52 Week High
- CNMD $78.19
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- CNMD 39.67
- RXRX 50.95
- Support Level
- CNMD $50.80
- RXRX $4.96
- Resistance Level
- CNMD $53.30
- RXRX $5.36
- Average True Range (ATR)
- CNMD 1.59
- RXRX 0.41
- MACD
- CNMD -0.37
- RXRX 0.02
- Stochastic Oscillator
- CNMD 16.23
- RXRX 22.96
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.